Diagnostic Cytopathology & Significance of Biopsy Investigation Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague https://www1.lf1.cuni.cz/~jdusk/

Slides:



Advertisements
Similar presentations
Introduction to Pathology By Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Advertisements

Fine Needle Aspiration Cytology - an overview Nor Hayati Othman Dept of pathology.
MANAGEMENT OF ABNORMAL PAP SMEAR
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Diagnostic Techniques for Endometrial Cancer By:Sara Lotfiyan.
Neoplasia 1: Introduction. terminology oncology: the study of tumors neoplasia: new growth (indicates autonomy with a loss of response to growth controls)
Introduction to Pathology. What is pathology Pathology is the scientific study of disease. In its broadest sense, it is the study of how the organs and.
IL BCCP Questions.
Updates on Pap Smear Guidelines 2014
Indicate conventional smear (Pap smear) vs. liquid based vs. other
Evolution of Neoplasia The Uterine Cervix As a Model Raj C. Dash, MD Duke University Medical Center Durham, North Carolina.
ASHLYN SAVAGE, MD, MSCR ASSOCIATE PROFESSOR OBSTETRICS AND GYNECOLOGY MEDICAL UNIVERSITY OF SOUTH CAROLINA Managing Abnormal Pap Smears: Incorporating.
Comparison of HPV Testing and Spectroscopy Combined with Cytology for the Detection of High- grade Cervical Neoplasia C Werner, W Griffith III, R Ashfaq,D.
COLPOSCOPY RANDOM CERVICAL BIOPSIES ENDOCERVICAL CURETTAGE S.C.P.M.G.-Fontana.
DIAGNOSTIC METHODS IN GYNECOLOGY
Screening for Cervical Cancer
Management of Women with CIN 1 or LSIL
Benign and premalignant disease of the cervix
Diseases of cervix.
FINE - NEEDLE ASPIRATION BIOPSY By Dr. Tarek Atia.
Cytopathology: Technique and Interpretation
Benign and Malignant Lesions in Respiratory Cytology
Cervical Cancer Screening
The Role of the Cytology Laboratory
Cytopathology-1 DR. MAHA AL-SEDIK.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
CERVICAL SCREENING WITH LUVIVA MACHINE FOR EARLY DETECTION OF CERVICAL DYSPLASIA: EXPERIENCE FROM EKITI STATE, NIGERIA Sunday O. Omoya, Abimbola M. Obimakinde.
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
MHD II Laboratory Session Cytology APRIL 24, 2014.
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Cytology and Cytological Techniques
CIN and mimics Dr Michael Coutts Consultant Gynaecological Pathologist
Screening for Cervical Cancer Dr. Shanthi Manivannan, MD.
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
International Scientific Congress for Students, Young Physicians and Pharmacists Marisiensis 2014.
Cervical Intraepithelial Neoplasm
Pathology Reports Nicole Draper, MD.
INTRODUCTION TO CYTOLOGY.
Top Pap smear Questions. 1-When should Pap screening begin? Age 21 y/o,3yrs after first intercourse.
The contents of pathology The contents of pathology   Aetiology (the causes )   Pathogenesis (mechanisms)   pathologic changes: structural & functional.
General Pathology Basic Principles of Cellular and Organ Pathology Oncology - II Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague.
Cytologic and DNA- Cytometric Early Diagnosis of Oral Cancer Torsten W. Remmerbach, Horst Weidenbach, Natalja Pomjanski, Kristiane Knops, Stefanie Mathes,
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
General Pathology I v Introduction v Methods. Pathology science on diseases – causes (etiology) – mechanisms of formation (pathogenesis) – development.
1 Cytology Cases September 10, Thinprep Pap (28 year old) A. AGC B. Reactive Endocervical Cells C. Atrophy D. HSIL E. Endometrial.
NEOPLASIA Def.: persistent abnormal
Gynecologic Cytopathology
General Pathology Basic Principles of Cellular and Organ Pathology Oncology - II Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague.
Cytopathology Feb Cytopathology at cellular level Study of pathological changes at cellular level. fluid or free cells Samples are fluid or.
What is a Pap smear? is a medical procedure in which a sample of cells from a woman's cervix is collected and spread (smeared) on a microscope slide.
Cytopathology Feb
Morphologic Pap Test Findings in HPV Negative Women Age 30 Years and Older: What Information Will Be Lost with HPV Only Primary Screening? Brooke Henninger,
44.
Inst. Pathol. ,1st Med. Faculty, Charles Univ., Prague
Medical Diagnostic Center- L.E.M
Cervical Cancer Colposcopy & Treatment
Hoa Nguyen Lam, Huyen Suong Ho Thi et al.
Department of Pathology
کنترل کيفی در سيتولوژی سرويکوواژينال
Introduction to Pathology By Dr. Gehan Mohamed Dr. Abdelaty Shawky
Inst. Pathol. ,1st Med. Faculty, Charles Univ., Prague
Figure 1: Guidelines for primary cytology# screening in South Africa
SH-sheikhhasani Gyn-oncologist
Presentation transcript:

Diagnostic Cytopathology & Significance of Biopsy Investigation Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague

Morphological Diagnostic Methods v Clinical v Pathological

Morphological Diagnostic Methods v Clinical: v macroscopy of lesions v visible with the naked eye v invisible with the naked eye - IMAGING (X-ray, sonography, scintigraphy, endoscopy, CT,…) v magnifying glass - colposcopy

Morphological Diagnostic Methods v Pathological v macroscopy v microscopy v ultrastructure v IMAGING

Morphological Diagnostic Methods v Pathological v macroscopy of lesions v autopsy report v biopsy description v cytology material description

Morphological Diagnostic Methods v Pathological v microscopy v cytology v minibiopsy - cytoblock v histology

Cytology (FNAB) u often both first and final dg. method u outpatient low cost procedure u done by an experienced (cyto)pathologist surprisingly effective u has some limits (!)

CYTOLOGY IS VERY EFFICIENT IN EARLY NEOPLASM DIAGNOSTICS

ESPECIALLY, IF CLINICO- MORPHOLOGICAL COMMUNICATION WORKS

Expectations Clinician from his pathologist: v confirmation of neoplasm dg. v nosological classification v grading, staging v prognosis v reaction to the therapy v recidive recognition

Expectations Pathologist from his clinician: v information: local.,size, duration, former dg. a treated neo, clin. dg. v diagnostic material acquisition v correct interpretation of the pathologist´s report

Getting Cytology Material u surface – smeared, brushed, scraped u cavities – punctured, aspirated u deep solid lesions - aspirated

Processing Cytology Material u smears u cytospins, cytosedimentation u cytoblock

Minibiopsy - Cytoblock from FNAB u advantage of easy material taking together with more tissue architecture information u histology &, immunohistochemistry methods available u multilayered tissue phragments readable

Cytology Material Staining u gynecology smears - polychrome u other materials –MGG, HE, polychrome, all other methods u cytoblock – multiple methods

Goals of Cytological Investigation u Screening – detection of symptomless lesions u Diagnosis of pathological lesions found v introductory (followed by histol.) v final

Gynecological oncologic cytology laboratory investigation standard Authors: MUDr Alena Beková, MIAC MUDr Pavel Tretiník, MIAC Oponents: doc. MUDr J. Dušková, CSc,FIAC MUDr Eva Svobodová

Cytology - Evaluation u staining and evaluation – minutes u Bethesda system : –material quality and quantity –group diagnosis –dg. as close to histology as possible –recommendation

Bethesda System 2001

Suitable for Evaluation u without limits u limited by… v non processed v processed but limited for evaluation of squamous cell abnormalities due to…..

General Categorisation u negative for intraepith. lesion or malignancy u intraepith. lesion or malignancy squamous or glandular u other pathology endometral cells in women over 40 yrs

Interpretation u negative for intraepithelial lesion or malignancy u Microorganisms v Trichomonas v mycosis vs. candidosis v shift - bact. vaginitis v bacteria Actinomyces like v cell changes of HSV type

Interpretation u negative for intraepithelial lesion or malignancy v Other non-neoplastic changes v reactive v inflammation (+ repair) v IUD v atrophy

Bethesda - cervical cytology classification 1. normal 2. benign cellular changes 3. ASCUS 4. L SIL 5. H SIL 6. Atypiae of glandular cells 7. susp. adenoca

Interpretation u epithelial abnormalities v squamous v ASC-US v ASC-H v LSIL CIN 1, HPV v HSIL CIN2, CIN3, CIS v susp. invasion v squamous ca

Interpretation u epithelial abnormalities v squamous v ASC-US v ASC-H v LSIL CIN 1, HPV v HSIL CIN2, CIN3, CIS v susp. invasion v squamous ca

Bethesda System 2001

Cytology getting sample u needle mm u min. 2 punctions v aspiration v nonaspiration – reduction of the blood content u cyst: evacuate and aspirate with the second punction the periphery u fluid: whole volume for cytology

Peroperation Biopsy u dg. during minutes u morphological artefacts (combination with cytology) u limited extensity of investigation u limited time

„Classical“ Biopsy (formol paraffin technique ) u simple may be done in two days u immuno reactions two days more u further sectioning two days more u oncol. dg. - WHO classification –typing, grading, staging –prognostic factors

Biopsy u any tissue removed from a living patient is a COMPULSORY subject to u do not follow the tendency to discard „unimportant“ materials (nevi, tonsillae, uteri, intestine, endometrial curretage…..) !

Biopsy u do not crush small samples taking imprint cytology !!! u adequate amount of fixation solution (sample: fixative = min. 1:10) u wide neck bottle tightly closed for transport but openable without rough violence u flat sample – spread and tighten on a bearing socket u mark discrete suspicious lesion with a stitch before fixation

CYTOLOGY LOVE IT or LEAVE IT L. Cardozzo